Reach Us +1-218-451-2974


Editor - Mark Agulnik | Northwestern University | 5316
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mark Agulnik

Mark Agulnik
Mark Agulnik
Division of Hematology/Oncology
Feinberg School of Medicine
Northwestern University
Northwestern University


Mark Agulnik, MD, is Assistant Professor of medicine in the Division of Hematology and Oncology at Northwestern University in Chicago, IL.

Dr. Agulnik earned his medical degree at McGill University School of Medicine in Montreal, Canada. After graduating, he completed his residency in internal medicine at Dalhousie University in Halifax, Nova Scotia. His fellowship in hematology and oncology was conducted at the University of Illinois at Chicago.  He subsequently completed a Clinical Research Fellowship at The University of Toronto’s Princess Margaret Hospital with a focus on Head and Neck Cancer.

Currently, Dr. Agulnik serves as Director of the Head and Neck and Sarcoma programs at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He also serves as the Fellowship Program Director for the Department of Hematology and Oncology. Dr. Agulnik is a member of the American Society of Clinical Oncology, as well as the Connective Tissue Oncology Society.  His research interests early drug development for both Head and Neck Cancers and Sarcomas. Dr. Agulnik is a panel member on both the National Comprehensive Cancer Network (NCCN) Bone Cancer Panel and Occult Primary Panel. He is a member of the National Cancer Institute Rare Tumors Task Force of the Head and Neck Cancer Steering Committee and an ECOG Head and Neck Cancer Committee Member.

Research Interest

His research interests early drug development for both Head and Neck Cancers,Salivary Gland Tumors, Thyroid Cancer and Sarcomas.



Global Speakers in the subject

Global Experts in the subject